In celebration of a century with insulin – Update of insulin gene mutations in diabetes

[1]  Jie Chang,et al.  MODY10 caused by c.309-314del CCAGCT insGCGC mutation of the insulin gene: a case report. , 2020, American journal of translational research.

[2]  Ming Liu,et al.  Biological behaviors of mutant proinsulin contribute to the phenotypic spectrum of diabetes associated with insulin gene mutations , 2020, Molecular and Cellular Endocrinology.

[3]  L. Donovan,et al.  Glycemic Impact of Metformin in Diabetes Caused by Heterozygous Insulin Gene Mutation R46Q. , 2020, Canadian journal of diabetes.

[4]  K. Hussain,et al.  Neonatal diabetes due to homozygous INS gene promoter mutations: Highly variable phenotype, remission and early relapse during the first 3 years of life , 2020, Pediatric diabetes.

[5]  B. Shirah,et al.  A homozygous mutation in the insulin gene (INS) causing autosomal recessive neonatal diabetes in Saudi families , 2020, Annals of pediatric endocrinology & metabolism.

[6]  L. Groop,et al.  Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study , 2019, Diabetes Care.

[7]  A. Hattersley,et al.  ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents , 2018, Pediatric diabetes.

[8]  R. Kaufman,et al.  Biosynthesis, structure, and folding of the insulin precursor protein , 2018, Diabetes, obesity & metabolism.

[9]  G. d’Annunzio,et al.  Genetic causes and treatment of neonatal diabetes and early childhood diabetes. , 2018, Best practice & research. Clinical endocrinology & metabolism.

[10]  L. Philipson,et al.  Monogenic Diabetes in Children and Adolescents: Recognition and Treatment Options , 2018, Current Diabetes Reports.

[11]  U. Oppermann,et al.  A novel INS mutation in a family with maturity‐onset diabetes of the young: Variable insulin secretion and putative mechanisms , 2018, Pediatric diabetes.

[12]  S. Ellard,et al.  Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation , 2018, Journal of pediatric endocrinology & metabolism : JPEM.

[13]  M. Lemelman,et al.  Neonatal Diabetes Mellitus: An Update on Diagnosis and Management. , 2017, Clinics in perinatology.

[14]  L. Philipson,et al.  Early Intensive Insulin Use May Preserve β-Cell Function in Neonatal Diabetes Due to Mutations in the Proinsulin Gene , 2017, Journal of the Endocrine Society.

[15]  Soo-young Park,et al.  In vivo measurement and biological characterisation of the diabetes-associated mutant insulin p.R46Q (GlnB22-insulin) , 2017, Diabetologia.

[16]  S. Levy,et al.  Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry , 2017, Diabetologia.

[17]  N. Crimmins,et al.  Bilateral cataracts in a 6‐yr‐old with new onset diabetes: a novel presentation of a known INS gene mutation , 2016, Pediatric diabetes.

[18]  S. Giglio,et al.  Clinical and molecular characterization of a novel INS mutation identified in patients with MODY phenotype. , 2016, European journal of medical genetics.

[19]  A. Hattersley,et al.  The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study , 2015, The Lancet.

[20]  C. Cortese,et al.  Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment , 2015, Acta Diabetologica.

[21]  Marie E. Perrone,et al.  Continued lessons from the INS gene: an intronic mutation causing diabetes through a novel mechanism , 2015, Journal of Medical Genetics.

[22]  T. Tankova,et al.  A family with permanent neonatal diabetes due to a novel mutation in INS gene. , 2015, Diabetes research and clinical practice.

[23]  O. Cinek,et al.  Frameshift mutations in the insulin gene leading to prolonged molecule of insulin in two families with Maturity-Onset Diabetes of the Young. , 2015, European journal of medical genetics.

[24]  A. Hattersley,et al.  Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes from the South-Eastern region of Turkey: predominance of non-KATP channel mutations , 2015, European journal of endocrinology.

[25]  A. Brzozowski,et al.  Structural and Functional Study of the GlnB22-Insulin Mutant Responsible for Maturity-Onset Diabetes of the Young , 2014, PloS one.

[26]  A. Hattersley,et al.  Permanent neonatal diabetes in siblings with novel C109Y INS mutation transmitted by an unaffected parent with somatic mosaicism , 2014, Pediatric diabetes.

[27]  N. Kamal,et al.  Permanent Neonatal DM in Monozygotic Twins with p.C109Y Mutation in INS Gene: First Report from Saudi Arabia , 2014 .

[28]  T. Ogata,et al.  Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 yr of age , 2013, Pediatric diabetes.

[29]  L. Harries,et al.  Permanent Neonatal Diabetes Caused by Creation of an Ectopic Splice Site within the INS Gene , 2012, PloS one.

[30]  M. Borowiec,et al.  Paternally Inherited Proinsulin Mutations May Result in Earlier Onset of Monogenic Diabetes Mutation Identity Effect in Monogenic Diabetes , 2011, Diabetes Care.

[31]  P. Arvan,et al.  Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth , 2010, Trends in Endocrinology & Metabolism.

[32]  D. Steiner,et al.  Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene , 2010, Reviews in Endocrine and Metabolic Disorders.

[33]  T. Hansen,et al.  Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY) , 2010, BMC Medical Genetics.

[34]  Soo-Young Park,et al.  In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes. , 2010, American journal of physiology. Endocrinology and metabolism.

[35]  A. Hattersley,et al.  Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis , 2010, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Steiner,et al.  Mutant proinsulin proteins associated with neonatal diabetes are retained in the endoplasmic reticulum and not efficiently secreted. , 2010, Biochemical and biophysical research communications.

[37]  O. Pedersen,et al.  Insulin Gene Mutations Resulting in Early-Onset Diabetes: Marked Differences in Clinical Presentation, Metabolic Status, and Pathogenic Effect Through Endoplasmic Reticulum Retention , 2009, Diabetes.

[38]  P. Arvan,et al.  Misfolded Proinsulin Affects Bystander Proinsulin in Neonatal Diabetes* , 2009, The Journal of Biological Chemistry.

[39]  D. Steiner,et al.  A brief perspective on insulin production , 2009, Diabetes, obesity & metabolism.

[40]  F. Meschi,et al.  Insulin Gene Mutations as Cause of Diabetes in Children Negative for Five Type 1 Diabetes Autoantibodies , 2009, Diabetes Care.

[41]  T. Hansen,et al.  Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. , 2008, The Journal of clinical investigation.

[42]  B. Shields,et al.  Insulin Mutation Screening in 1,044 Patients With Diabetes , 2008, Diabetes.

[43]  Geir Joner,et al.  Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes , 2008, Diabetes.

[44]  A. Hattersley,et al.  Insulin gene mutations as a cause of permanent neonatal diabetes , 2007, Proceedings of the National Academy of Sciences.

[45]  E. Wolf,et al.  Dominant-Negative Effects of a Novel Mutated Ins2 Allele Causes Early-Onset Diabetes and Severe β-Cell Loss in Munich Ins2C95S Mutant Mice , 2007, Diabetes.

[46]  K. Docherty,et al.  Comparative Analysis of Insulin Gene Promoters , 2006, Diabetes.

[47]  B. Yusta,et al.  GLP-1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress , 2006 .

[48]  M. Prentki,et al.  Glucagon-like peptide-1 prevents beta cell glucolipotoxicity , 2004, Diabetologia.

[49]  H. Noushmehr,et al.  Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. , 2003, Endocrinology.

[50]  D. Ron.  Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse. , 2002, The Journal of clinical investigation.

[51]  W. Rutter,et al.  The Insulin Gene Is Located on the Short Arm of Chromosome 11 in Humans , 1981, Diabetes.

[52]  Howard M. Goodman,et al.  Sequence of the human insulin gene , 1980, Nature.

[53]  W. Rutter,et al.  Nucleotide sequence of a cDNA clone encoding human preproinsulin , 1979, Nature.

[54]  R. Ganesh,et al.  Neonatal diabetes: A case series , 2016, Indian Pediatrics.

[55]  S. Ellard,et al.  Permanent neonatal diabetes caused by a novel mutation in the INS gene. , 2013, Diabetes research and clinical practice.

[56]  Stephen O’Riordana,et al.  Insulin mutation screening in 1 , 044 patients with diabetes : mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood , 2008 .

[57]  Danhong Lu,et al.  A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. , 1999, The Journal of clinical investigation.

[58]  D. Steiner,et al.  Structure and evolution of the insulin gene. , 1985, Annual review of genetics.